BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Breakpoint Cluster Region-Abelson kinase (BCR–Abl) is the driver mutation for chronic myeloid leukemia (CML) and is also found in 25% to 30% of Philadelphia chromosome–positive (Ph+) adult acute lymphoid leukemia (ALL) (1, 2).